Esomeprazole Sodium

艾司奥美拉唑钠

Report date: 2026/03/30 17:02:26

Base Information

Drug NameEsomeprazole Sodium
Drug Alias Name艾美拉唑钠(S)-Omeprazole sodiumNatrii Esomeprazolum埃索美拉唑钠esomeprazole +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitors
TargetsProton pump
Therapy Area/IndicationsSkin UlcerMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases +[12] 
Global Approved IndicationsEsophagitisGastroesophageal Reflux
Approved Indications in ChinaEsophagitisGastroesophageal Reflux
Original Approved Country/TerritorySweden
Original Approved Date2003/01/01
Country/TerritoryUnited StatesSwedenRussian Federation +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGruenenthal Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesIrccs Azienda Ospedaliera Universitaria San Martino - Ist - Istituto Nazionale Per La Ricerca Sul CancroAstrazeneca Pharmaceutical Co LtdRush University Medical Center +[4] 
Inactive CompaniesAstrazeneca Pharmaceuticals LpChinese University Of Hong Kong (Cuhk)
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver DiseasesEsophagitis +[7] 
Inactive IndicationsSkin UlcerStomach UlcerDuodenal Ulcer +[5] 

Other Information

ATC CodeA02BC05
Related LinksWikipediaDrugBankKEGG